Riskpilot← Back to searchSign inGet full accessMANDAL SMÅDYRKLINIKK AS
ASActiveOrg 921500734Langgata 15D, 4515 MandalVeterinary activities · NACE 7500Est. 20187 employees
Revenue 2022
NOK 7,5M
0% vs 2021
EBITDA margin
8.8%
-24% vs 2021
Equity ratio
19.0%
Financial strength
Net profit 2022
NOK 233K
-45% vs 2021
| Revenue | NOK 7,5M | +0% |
| EBITDA | NOK 664K | -24% |
| Net profit | NOK 233K | -45% |
| Total assets | NOK 3,3M | +2% |
| Equity | NOK 634K | +58% |
| Employees | 7 | — |
Legal name
MANDAL SMÅDYRKLINIKK AS
Org number
921500734
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
3. oktober 2018
Share capital
NOK 10 000 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Company purpose
Salg av veterinærtjenester og andre produkter som naturlig faller sammen med dette, herunder å delta i andre selskaper med lignende virksomhet.
Address
Langgata 15D, 4515 Mandal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Revenue | 5 967 | 6 728 | 7 495 | 7 521 |
| Staff expenses | −2 172 | −2 534 | −2 840 | −3 096 |
| EBITDA | 838 | 1 001 | 878 | 664 |
| Depreciation & amort. | −317 | −325 | −244 | −306 |
| EBIT | 521 | 677 | 633 | 358 |
| Net financials | −95 | −95 | −84 | −59 |
| Profit before tax | 426 | 582 | 550 | 299 |
| Tax | −0 | 103 | 122 | 66 |
| Net profit | 426 | 479 | 427 | 233 |
| Item | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Total assets | 3 660 | 4 013 | 3 261 | 3 340 |
| Equity | 881 | 1 083 | 401 | 634 |
| Long-term debt | 2 041 | 1 900 | 1 704 | 126 |
| Short-term debt | 738 | 1 030 | 1 156 | 2 580 |
| Total debt | 2 779 | 2 931 | 2 860 | 2 706 |
EBITDA margin
8.8%
This company
15.8%
Market median
-44% vs market
20192022
Equity ratio
19.0%
This company
38.2%
Market median
-50% vs market
20192022
Return on equity
36.8%
This company
18.4%
Market median
+100% vs market
20192022
Net profit margin
3.1%
This company
8.1%
Market median
-62% vs market
20192022
Asset turnover
2.25×
This company
1.12×
Market median
+101% vs market
20192022
Debt / equity
4.27×
This company
0.62×
Market median
-589% vs market
20192022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2018-09-10 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TN Chief Executive Officer | Chief Executive Officer | 2018 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Evidensia Dyrehelse As
MANDAL SMÅDYRKLINIKK AS Board members of MANDAL SMÅDYRKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Nymoen | Chief Executive Officer | 0 companies |
| Cecilie Ryan Yttreeide | Chairman | 0 companies |